Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms

Murtadha Al-Khabori, MD, Shoaib Al-Zadjali, PhD, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, MD, Mohamed Al Huneini, MD, Naglaa Fawaz, MBBChir, MMSc, PhD, Al Lamki Sulayma, MD, Mahdiya Pir Al Bulushi, MD FRCPC, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi

Blood (2019) 134 (Supplement_1): 5383.

https://doi.org/10.1182/blood-2019-128309

Published: 2019

Journal Articles

The Optimal Cut-Off Level for Hemoglobin A2 to Differentiate between Sickle Cell Disease Genotypes

Fayiz Al Shueili, MD, Murtadha K. Al-Khabori, BSc,MD FRCPC, MSc, Salam Al-Kindi, Yasser Wali, MD, Shoaib Al-Zadjali, PhD

Blood (2018) 132 (Supplement 1): 2391.

https://doi.org/10.1182/blood-2018-99-118697

Published: 2018

Journal Articles

Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

Murtadha K. Al-Khabori, BSc, MD FRCPC,MSc, Shoaib Al-Zadjali, PhD, Mohamed Al-Rawahi, BSc, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, Mohamed Al Huneini, Al Lamki Sulayma, MD, Mahdiya Al-Belushi, MD, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi

Blood (2018) 132 (Supplement 1): 5489.

https://doi.org/10.1182/blood-2018-99-118546

Published: 2018

Journal Articles

Influence of Genetic Modifiers on Levels of Invariant Natural Killer T-Cells in Patients with Sickle Cell Anemia

Ahmed Al-Yarabi, Tahar Al-Shabibi, Nasser Ambu-Ali, Shoaib Al-Zadjali, Abeer Al-Zubaidi, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Mohammed Al-Huneini, Salam Al-Kindi, Yasser Wali, Mohamed-Rachid Boulassel, DEMS, PhD

Blood (2016) 128 (22): 4843.

https://doi.org/10.1182/blood.V128.22.4843.4843

Published: 2016

Journal Articles

Circulating Invariant Natural Killer T Cell Subsets Are Functionally Preserved in Splenectomized Children with Sickle Cell Disease Compared to Patients with Large Spleen

Mohamed-Rachid Boulassel, DEMS, PhD, Abeer Al-Zubaidi, Ismail Beshlawi, Zahra Al-Qarni, Nidaa Al-Naamany, Shoaib Al-Zadjali, Sulaiman Al-Hashmi, Hamad Khan, Mohammed Al Huneini, Khalil Al Farsi, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Salam Al-Kindi, Yasser Wali

Blood (2015) 126 (23): 3389.

https://doi.org/10.1182/blood.V126.23.3389.3389

Published: 2015

Journal Articles

Outcome of Early Introduction of Hypertransfusion/Chelation Program in Children with Thalassemia Intermedia

Yasser Wali, MD, FRCPCH, (UK), A. Hakim Al-Rawas, MD, Shoaib Al Zadjali, M Sc, Murtadha K. Al-Khabori, MD, MSc, FRCPC, Wafa Bashir, MD, Mathew Zachariah, MD, Taimoora Sulaiman, MD, Surekha Tony, MD

Blood (2012) 120 (21): 3260.

https://doi.org/10.1182/blood.V120.21.3260.3260

Published: 2012

Journal Articles

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Surekha Tony, MD, Shahina Daar, MD, PhD, Shoaib Al Zadjali, MSc, Murtadha K. Al-Khabori, MD, FRCPC, Mohammed El Shinawy, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5304.

https://doi.org/10.1182/blood.V118.21.5304.5304

Published: 2011

Journal Articles

Inherited Thrombophilia In Omani Women with Recurrent Pregnancy Loss

Khalil Al Farsi, MD, FRCPC, Shoaib Al Zadjali, MSc, Karima Al Falahi, BSc, Murtadha K. Al-Khabori, MD, FRCPC, Anil Pathare, MD, FCPS, FIMSA, Ph.D, Salam Alkindi, BA, MB, BCh, BAO, DME, MSc, FRCP

Blood (2010) 116 (21): 5124.

https://doi.org/10.1182/blood.V116.21.5124.5124

Published: 2010

Journal Articles

Newborn Haemoglobinopathy Carrier Screening: Towards Comprehensive and Improved Patient Care of Sickle Cell Disease in Oman, a Cost Effective Analysis.

Salam Alkindi, MD, Anil Pathare, MD, Ali Al Madhani, MD, Shoaib Al Zadjali, M.Sc, S. Muralitharan, Ph.D, Hamood Al Haddabi, M.Sc, Qamariya Al Abri, M.Sc, David Gravell, M.Sc, Shahina Daar, MD, J. David Dennison, MD, R. Krishnamoorthy, Ph.D

Blood (2007) 110 (11): 5155.

https://doi.org/10.1182/blood.V110.11.5155.5155

Published: 2007

Journal Articles

Suboptimal Busulphan Exposure Is Associated with Mixed Hematopoietic Chimerism, a Risk Factor for Rejection in Bone Marrow Transplantation for Homozygous beta Thalassemia.

J. David Dennison, MD, Shoaib Al Zadjali, Melanie Tauro, Salam Al Kindi, MD, S. Muralitharan, Krishnaratnam Kanan, MD, Shahina Daar, MD, Anil Pathare, MD, Marie-Helene Quernin, Evelyne Jacqz-Aigrain, MD, R. Krishnamoorthy, MD, Shyam Sundar Ganguly, MD

Blood (2004) 104 (11): 1149.

https://doi.org/10.1182/blood.V104.11.1149.1149

Published: 2004

NARROW

Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms

The Optimal Cut-Off Level for Hemoglobin A2 to Differentiate between Sickle Cell Disease Genotypes

Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

Influence of Genetic Modifiers on Levels of Invariant Natural Killer T-Cells in Patients with Sickle Cell Anemia

Circulating Invariant Natural Killer T Cell Subsets Are Functionally Preserved in Splenectomized Children with Sickle Cell Disease Compared to Patients with Large Spleen

Outcome of Early Introduction of Hypertransfusion/Chelation Program in Children with Thalassemia Intermedia

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Inherited Thrombophilia In Omani Women with Recurrent Pregnancy Loss

Newborn Haemoglobinopathy Carrier Screening: Towards Comprehensive and Improved Patient Care of Sickle Cell Disease in Oman, a Cost Effective Analysis.

Suboptimal Busulphan Exposure Is Associated with Mixed Hematopoietic Chimerism, a Risk Factor for Rejection in Bone Marrow Transplantation for Homozygous beta Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only